The process in which a T cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.

An immune response dependent upon secreted immunoglobulin. An example of this process is found in Mus musculus.

The deletion of B cells by apoptotic process occurring as part of peripheral tolerance induction and B cell selection.

The apoptotic death of B cells which is part of B cell tolerance induction.

Any process contributing to anergy, a state of functional inactivation that occurs as part of tolerance induction, in peripheral B cells.

Any process contributing to anergy in B cells, a state of functional inactivation which is part of B cell tolerance induction.

The process of replacing receptors on B cells, in which RAG gene expression allows continued light-chain gene rearrangement and expression of a new light change which combines with the previous heavy chain to form a new receptor.

The process in which immunoglobulin genes are formed through recombination of the germline genetic elements, as known as immunoglobulin gene segments, within a single locus.

Tolerance induction of mature B cells in the peripheral lymphoid tissues: the blood, lymph nodes, spleen, and mucosal-associated lymphoid tissue.

A process involving any mechanism for tolerance induction in B cells.

The process in which a B cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex.

Any process involved in the carrying out of an immune response by an eosinophil.

A chronic inflammatory response to an antigenic stimulus. A chronic inflammatory response persists indefinitely during days, weeks, or months in the life of an individual.

The process of immune complex clearance by monocytes or macrophages.

A process directed at removing immune complexes from the body. Immune complexes are clusters of antibodies bound to antigen, to which complement may also be fixed, and which may precipitate or remain in solution.

The process of immune complex clearance by erythrocytes. The process often starts with binding of complement receptor 1 (CR1) on the surface of erythrocytes to a complement coated immune complex. The complex bound to erythrocyte CR1 is then transported to the liver or spleen where it is presented to phagocytes. The process ends when the complex is removed from CR1, allowing the erythrocyte to return to general circulation.

The formation of nodular inflammatory lesions, usually small or granular, firm, persistent, well-structured, and containing compactly grouped T lymphocytes and modified phagocytes such as epithelioid cells, giant cells, and other macrophages. Granuloma formation represents a chronic inflammatory response initiated by various infectious and noninfectious agents. The center of a granuloma consists of fused macrophages, which can become necrotic.

Tolerance induction taking place in the mucosal tissues.

An immune response taking place in mucosal tissues, including those of the intestinal tract, nasal and upper respiratory tract, and genital tract.

The synthesis and release of immunoglobulin in the mucosal tissue.